Clinical Trial Detail

NCT ID NCT03023046
Title Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of Washington
Indications

acute lymphocytic leukemia

lymphoblastic lymphoma

Therapies

Rituximab

Doxorubicin

Etoposide

Imatinib

Dasatinib

Cyclophosphamide

Prednisone

Vincristine

Age Groups: senior adult

No variant requirements are available.